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Abstract
Objectives: West Nile virus (WNV) is a mosquito-borne flavivirus that is naturally sustained in
a Culex mosquito-bird-mosquito transmission cycle and can cause disease in birds, equines, and
humans. Most human infections with WNV are asymptomatic; however, West Nile fever
(WNF), or West Nile neuroinvasive disease (WNND) can develop and be fatal in some
circumstances. Between 2005 and 2021 there have been over 1,800 cumulative cases of WNV in
Nebraska, which currently ranks as fourth in the United States for reported cases. WNV cases are
a mandatory reportable disease in Nebraska through an electronic reporting system managed by
the Nebraska Department of Health and Human Services (NDHHS). This passive surveillance
system has been in place since 2005; however, no analysis has been done on WNV surveillance
data in Nebraska. The objective of this study is to examine trends in WNV infections in
Nebraska from 2005-2021 and examine characteristics between WNF and WNND cases between
2005 and 2021.
Methods: To examine the burden of WNV disease in Nebraska, descriptive epidemiology using
data reported in Nebraska Electronic Disease Surveillance System (NEDSS) from 2005-2021
was performed using the SAS analysis tool. WNF and WNND cases were compared using Chi
Square analysis, and predictors for developing WNND were examined by logistic regression
analysis. Finally, maps to visualize the cumulative incidence by local health department (LHD)
jurisdictions were created using ArcGIS software.
Results: 1,822 cases met the inclusion and exclusion criteria for analysis. Case counts have
varied every year between 2005-2021, with noticeable outbreaks occurring in 2006, 2013, and
2018. The average cumulative incidence for Nebraska between 2005-2021 was 5.86 cases per
100,000 people. Urban residence, people aged 65+, Hispanic ethnicity, and races other than
white or black were significant predictors for developing WNND.
Conclusion: The overall burden of WNV in Nebraska remains higher than the national average.
Continued surveillance and better understanding of the distribution of disease across Nebraska
create the best opportunity for utilization of prevention and control resources.
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Abbreviations
Abbreviation
WNV
WNF
WNND
CDC

Definition
West Nile Virus
West Nile Fever
West Nile Neuroinvasive Disease
Centers for Disease Control and Prevention
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Background
Origin and Emergence of WNV in Nebraska
West Nile virus (WNV) is an enveloped positive sense single-stranded RNA virus
belonging to the Flaviviridae family, Flavivirus genus [1]. It was first discovered in 1937 in the
West Nile region of northern Uganda and has subsequently spread across the world [2]. WNV
was first identified in the United States in New York, New York in 1999 [3]. In the years
following, WNV rapidly spread across the country causing significant disease burden and death.
WNV was first detected in Nebraska in 2002 and has resulted in 4,122 total cases as of
2021 [4]. WNV is the most frequently reported vector-borne disease in Nebraska, which
consistently ranks among the top ten in the United States for reported human cases per year [45]. Large WNV disease outbreaks have occurred in Nebraska, most recently in 2018, where 251
WNV disease cases were reported, the most reported cases in the United States that year [4]. The
largest outbreak in Nebraska to date was in 2003, when 1,942 cases were reported [4].
Transmission
WNV is driven by a continuous enzootic transmission cycle between mosquitoes and
birds. Many different mosquitoes can transmit WNV, but several among the Culex species are
thought to be the common mosquito vector of WNV [6]. The Culex tarsalis mosquito is the most
common WNV vector in Nebraska [7]. Birds serve as the reservoir and amplifying hosts of
WNV. Human, equines, and other vertebrate animals are considered “dead-end” hosts for WNV
due to the low level of viremia, which is not sufficient for the virus to be transmitted to
mosquitoes, thus ending the transmission cycle [8]. Transmission of WNV to humans is complex
but occurs when significant viral amplification occurs in bird populations which allows bridging
vector mosquitoes to transmit the virus to humans. WNV enters a mosquito through a bloodmeal
of an infectious bird, where the virus eventually infects the mosquito’s salivary glands, after
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which the mosquito becomes capable of transmitting the virus to susceptible hosts during future
bloodmeals [2,9].
Corvids (e.g. American crows and blue jays) are particularly susceptible to WNV
infection which can lead to an increase in bird mortality, an indicator that WNV is present in the
area [2]. The magnitude of transmission to humans is dependent on several factors including the
abundance of susceptible and infected birds and mosquitoes, human exposure, as well as
environmental conditions such as vegetation and ground cover [10]. Climate is also thought to
play role in WNV transmission, and a study in Nebraska that modeled climate, precipitation,
human WNV cases and population found that warm temperatures and a dry year preceded by a
wet year were the strongest predictors of cases of WNV [11].
Clinical Manifestation and Diagnosis
Most (approximately 80%) WNV infections are asymptomatic [12-13]. For symptomatic
infections, the onset of symptoms typically follows an incubation period of 2-14 days [13]. An
estimated 20% of WNV infections develop West Nile fever (WNF), which includes symptoms
such as fever, headache, tiredness, body aches, nausea, vomiting, occasionally a skin rash and
swollen lymph glands [12-13]. Approximately, 0.7% of people with a WNV infection develop
more severe disease, West Nile neuroinvasive disease (WNND), which includes symptoms such
as headache, high fever, neck stiffness, stupor, disorientation, coma, tremors, convulsions,
muscle weakness, and paralysis [12-13].
Public Health Surveillance
Nebraska Department of Health and Human Services (NDHHS) has developed the West
Nile Virus Surveillance Program, which is a statewide partnership between local health
departments, local vector control agencies, the Nebraska Public Health Laboratory, and the
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NDHHS Epidemiology Unit to test mosquitoes, dead birds, and human samples for WNV
infection [14].
WNV is a mandatory reportable disease, in which positive diagnostic tests from hospitals,
clinics, and laboratories are reported to NDHHS and to local health departments for case
investigations. Reporting is done by telephone, facsimile, other secure electronic mail system,
or automated reporting systems such as electronic laboratory reporting or electronic case
reporting. Information collected during the investigation includes demographic information,
clinical symptoms, hospitalization status and dates, and mortality, among other variables [14].
Current surveillance measures likely underestimate the total number of WNF cases in
Nebraska, particularly for asymptomatic and mild-to-moderate infection. Previous research has
suggested that for every WNND case there are 30-70 WNF cases, which would suggest that there
has been anywhere from 24,000 – 56,000 WNF cases in Nebraska since 2002 [25].
Prevention
There are currently no available human vaccines for WNV, so the key to reducing the
risk of WNV is reducing mosquito bites. Educating public health officials and the public more
broadly regarding the seriousness of mosquito transmitted diseases like WNV and how they can
prevent mosquito bites is crucial to reducing WNV disease burden. NDHHS serves as a resource
for local health departments for information on mosquito surveillance, education, prevention, and
control. Prevention measures for WNV transmission include reducing exposure through
eliminating mosquito breeding habitats and using personal protective measures. Public education
can encourage property owners to eliminate sources of standing water such as puddles in lowlying areas, bird baths, and gutters. Mosquito control aims to eliminate and prevent WNV
transmission in areas using different chemicals to kill either adult mosquitos or larvae. Local
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communities or health departments make the final decision regarding mosquito control
activities. Communities are responsible for developing, maintaining, and financing local
mosquito control programs.
Economic Burden
There has been no economic burden analysis done on WNV cases in Nebraska to date.
However, research has estimated that WNV disease cost nearly $780 million dollars between
1999-2012 in direct health care expenditures and indirect costs such as loss of productivity [28].
Individual estimated medical care and hospitalization costs vary from state to state but estimates
found higher costs associated with WNND cases in both direct and indirect costs. Estimates from
one study found that cases with encephalitis had health care costs ranging from approximately
$4,000 to $325,000, while cases with acute flaccid paralysis had medical care costs ranging from
$5,000 to $283,000. WNF cases had estimated costs ranging from $500 to $24,000 [32]. Other
studies have found outbreaks of 175 or less cases have estimated costs anywhere from $1.7
million to nearly $10.9 million when considering both medical and non-medical costs [33-35].
WNV disease likely creates a considerable economic burden on Nebraska as well, however,
more research is needed to get a better understanding of costs associated with the disease.
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Project Aims
Specific Aim 1: Describe the burden of West Nile Virus (WNV) cases in Nebraska from
2005 - 2021. This aim utilized NDHHS WNV case surveillance data to perform descriptive
statistics, as well as examine annual and cumulative incidence rates for Nebraska during that
period.
Specific Aim 2: Compare the clinical characteristics between West Nile fever (WNF)
and West Nile neuroinvasive disease (WNND) human cases in Nebraska between the years
2005-2021. This analysis explored significant differences by age groups, sex, and rural
residence. This information contributed to the current knowledge of WNV disease and risk
factors in Nebraska.
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Methods:
Study Design
This project is a retrospective, epidemiological analysis using public health surveillance
data among WNV infections among humans in Nebraska between 2005 -2021.
Data Sources
WNV case investigation data was obtained from NDHHS through their tracking system,
Nebraska Electronic Disease Surveillance System (NEDSS). A dataset with all case
investigations between 2005-2021 was provided for analysis. The NDHHS uses a standardized
case history form to collect demographic and clinical information about cases that meet specific
criteria for WNV disease. Variables collected through the surveillance system included race,
gender, year of birth, date of onset, hospitalization status, and clinical symptoms. Population
estimates were obtained from the US Census Bureau (http://www.census.gov) for annual and
cumulative incidence calculations. Case investigations are assigned either a WNF or WNND
designation depending on lab testing and clinical symptoms. The only asymptomatic cases
included in the dataset were positive viremic blood donor cases, which will be excluded from
analysis.
Rurality was defined for each case based on the Rural-Urban Commuting Area Codes
(RUCA) coding system. The system has assigned every zip code in the US with a number
between 1-10 based on population density, urbanization, and daily commuting [24]. Urban
residency is defined as a code value between 1-3, and rural residency was defined as a code
value between 4-10 [29].
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Data Cleaning
The dataset was obtained from NDHHS which included surveillance data on WNV case
investigations in Nebraska between 2005-2021. The dataset originally contained 2,972 case
investigations. There were 1,847 cases that met the case definition requirement for analysis
including 803 confirmed cases and 1,044 probable cases. The remaining 1,125 cases that were
removed from the dataset consisted of 4 cases listed as “NULL”, 1,060 cases listed as not a case,
and 61 cases listed as suspect cases. The dataset also included 13 cases that were identified
through blood donor screening. These cases were also removed due to the inability to determine
when the infection may have occurred and which condition class they may have been.
Additional data was removed from the analysis. There were 4 cases in which the
jurisdiction or residence of the person was not in Nebraska. This included 1 person with a
jurisdiction listed as “310023”, 2 cases with a jurisdiction listed as “Alpha DHD” (for Training
Only), and 1 case with a jurisdiction listed as “Iowa.” Additionally, there were 8 cases listed with
“Sandhills District Health Department” which is no longer a health district in Nebraska. The
final dataset included 1,822 cases that met the eligibility criteria for analysis.

Analysis
The data were analyzed using SAS Studio 3.8 (Enterprise Edition) software. Descriptive
statistics included case counts (N) and percentages (%) between WNF and WNND cases.
Included in the analysis were total cases, age groups (0-15, 16-24, 25-44, 45-64, 65+), gender,
ethnicity, race, hospitalization, rural residence, clinical symptoms, and deaths.
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An epidemiological curve of the cumulative case onset date by the epidemiologic week
was created to help visualize and compare Nebraska WNV data to previous research. Each bar in
the histogram was stratified by both WNV and WNND cases.
Annual incidence rates per 100,000 population were calculated using the case totals for
each year divided by the annual Nebraska population estimate (http://www.census.gov) for each
year between 2005-2021. Cumulative incidence rate per 100,000 population were calculated
using the total number of cases between 2005-2021 divided by the multiplication of the 2010
Nebraska population (http://www.census.gov) and 17 years. Additionally, the cumulative
incidence rate for each local health district in Nebraska were calculated and displayed on a map
of Nebraska. This will be calculated by taking the number of cases between 2005 to 2021 in each
district and divided by the multiplication of the sum of the county’s population in each district
based on the 2010 Nebraska census and 17 years.
There are 19 local health districts: Panhandle, North Central, West Central, Southwest,
Loup Basin, Two Rivers, East Central, Central, South Heartland, Four Corners, Public Health
Solutions, Northeast, Dakota, Elkhorn Logan Valley, Three Rivers, Douglas County, Sarpy/Cass
County, Lincoln/Lancaster County, and Southeast. Finally, the average annual incidence rates
per 100,000 population of WNF and WNND were calculated using case counts of WNF and
WNND cases and the population estimate for the respective year.
To compare the characteristics between WNF and WNND, several analyses will be done.
Categorical data (e.g. gender, rurality, age, hospitalization status) was analyzed using Chi-square
test to determine if there a significant difference between WNF and WNND groups. Fisher’s
Exact test was used in instances where cell counts were 5 or less. Finally, to identify if gender,
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age group, and rurality were predictive factors for developing WNND versus WNF, a logistic
regression analysis was performed. Odds ratios and 95% confidence intervals based on the
logistic regression were calculated. An association was considered statistically significant when
the p value was equal or less than 0.05 (p£0.05).
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Results
Table 1 presents the demographic and clinical characteristics of reported WNV cases in
Nebraska. Median age of all cases was 51 years (range 1-94 years), while the median age of
WNF cases was 48 years (range 1-94 years) and the median age of WNND cases was 55 years
(range 6-92 years). There were 56 deaths (3.1%) in Nebraska associated with WNV infections, 9
WNF cases and 48 WNND cases. The median age of the cases that died was 75 years (range 3092 years). For both WNF and WNND, the 45-64 age group comprised of the largest number of
cases (41% and 39%, respectively). A majority (57%) of all WNV infections have occurred in
males. For WNF, 744 (55%) of the cases were male compared to 301 WNND cases (61%; p=
0.05). As expected, a greater proportion of WNND (87%) cases were hospitalized compared to
WNF cases (24%; p <0.0001). Overall, cases were predominantly from rural residences (65%).
WNF had a larger proportion of cases from rural residences (70%) compared to WNND (52%;
p< 0.0001). A large portion of both the WNF and WNND cases had unreported or unknown
ethnicity (63% and 48%, respectively). From the responses that were collected, WNND had a
larger proportion of cases listed as not Hispanic or Latino (49%) compared to WNF (36%).
Similarly, a large proportion of the WNF cases (56%) had race not reported or listed as
unknown. Both WNF and WNND cases were predominately white (43% and 68%, respectively).
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Table 1. West Nile Virus Case Characteristics, Nebraska, 2005-2021.
Variable
Total Cases
Age Group
0-15
16-24
25-44
45-64
65+
Median
Gender
Male
Female
Unknown
Ethnicity
Hispanic or Latino
Not Hispanic or Latino
Unknown/Not Reported
Race
American Indian or Alaska Native
Asian
Black or African American
White
Multiracial
Unknown/Not Reported
Hospitalization
Hospitalized
Not Hospitalized
Unknown/Not Reported
Rural Residence
Rural
Urban
Unknown/Not Reported
Clinical Symptoms
Acute flaccid paralysis
Encephalitis - Including Meningoencephalitis
Febrile Disorder
Meningitis
Other Neuroinvasive
Other Clinical - Not Defined
Unknown/Not Reported
Deaths
Died
Survived
Unknown/Not Reported
* Chi Square test

WNF (%)
1331 (73)

WNND (%)
491 (27)

Total
1822

P-Value*

54 (4)
92 (7)
380 (28)
542 (41)
263 (20)
48

10 (2)
20 (4)
103 (21)
192 (39)
166 (34)
55

64
112
483
734
429
51

<0.0001

744 (55)
586 (44)
1 (0.1)

301 (61)
190 (39)
0 (0)

1045
776
1

0.0519

12 (0.9)
490( 36)
848 (63)

16 (3)
238 (49)
237 (48)

28
728
1085

<0.0001

0 (0)
1 (0.07)
9 (0.7)
606 (43)
0 (0)
741 (56)

4 (0.8)
0 (0)
15 (3)
336 (68)
1 (0.2)
137 (28)

4
1
24
942
1
878

<0.0001

327 (24)
965 (73)
39 (3)

428 (87)
59 (12)
4 (0.8)

755
1024
43

< 0.0001

932 (70)
350 (26)
49 (4)

258 (52)
231 (47)
2 (0.4)

1190
581
51

< 0.0001

0 (0)
0 (0)
182 (13.7)
0 (0)
0 (0)
45 (3.4)
1104 (82.9)

2 (0.4)
129 (26.3)
0 (0)
101 (20.6)
5 (1.0)
0 (0)
254 (51.7)

2
129
182
101
5
45
0

<0.0001

9 (0.7)
1139 (85.6)
183 (13.7)

47 (9.6)
372 (75.7)
72 (14.7)

56
0
0

<0.0001
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Figure 1. shows the deaths associated with WNV were largely among the 65+ age group
(78%) compared to the younger age groups. The two youngest age groups, 0-15 and 16-24, had
no deaths reported between 2005-2021.

Figure 1. West Nile Virus Associated Deaths by Age Group, Nebraska, 2005-2021.

WNV Associated Deaths by Age Group, Nebraska, 20052021
50
45

Death Counts

40
35
30
25
20
15
10
5
0
0-15

16-24

25-44

45-64

65+

Age Group

A total of 1,822 cases were included for the analysis, and the case counts ranged from
267 (2006) to 15 (2020). Figure 2. shows the case counts for all WNV cases reported in
Nebraska between 2005-2021. Three years, 2006, 2012 and 2018 had a spike in cases with the
preceding year being substantially lower. In 2006, the total case count for the year was over 11
times greater than the previous year. In 2012, there were 190 cases included for analysis, which
was nearly 7 times greater than the cases reported in 2011. In 2013 and 2014 there continued to
be elevated case counts with 229 and 141 cases reported, respectively. Finally, in 2018, a total of

16

251 cases were included in the analysis, which was over 3 times the number of cases reported in
2017.

Figure 2. West Nile Virus Disease Cases Reported by Year, Nebraska, 2005-2021

WNV Disease Cases Rerported By Year, Nebraska, 2005-2021
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Figure 3. displays the annual incidence rates per 100,000 people of WNF and WNND
cases in Nebraska between 2005-2021. The annual incident rates for WNF ranged from a low of
0.31 per 100,000 people in 2020 to the highest rate of 15.06 per 100,000 people in 2006. There
have been three peak years for WNF incidence, as seen in Figure 3. The peak years were 2006,
2013 with an incident rate of 9.38 per 100,000 people, and 2018 with an incident rate of 6.60 per
100,000 people. The annual incidence rates for WNND ranged from a low rate of 0.00 per
100,000 people in 2006 to the highest rate of 6.44 per 100,000 people in 2018. As expected,
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WNF incidence rates were more often higher than WNND incidence rates. However, in recent
years, 2019-2021 has shown WNND to have slightly higher incidence rates than WNF.

Figure 3. Annual WNF and WNND Case Incidence Rate per 100,000, Nebraska, 2005-2021

Nebraska Average Annual WNV Human Case Incidence Rate per 100,000,
2005-2021
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In Figure 4, the cumulative WNV cases for each LHD jurisdiction from 2005-2021 are
shown. The three LHD jurisdictions with the highest cumulative case counts were Douglas
County with 223 cases, Panhandle Public Health District with 208 cases, and Two Rivers Public
Health Department with 177 cases. The three LHD jurisdictions with the lowest cumulative case
counts were Dakota County Health Department with 6 cases, Southeast District Health
Department with 17 cases, and Northeast Nebraska Public Health Department with 31 cases.
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2021

Figure 4. Total WNV Cases by Local Health Department Jurisdiction, Nebraska, 20052021.

Cumulative WNV incidence rates per 100,000 population by LHD are depicted in Figure
5. The West Central District Health Department jurisdiction had the highest incidence rate of all
LHDs at 18.20. The other jurisdictions with high incidence rates included Panhandle Public
Health District (13.84), Loup Basin Public Health Department (13.79), and North Central
District Health Department (11.66). The jurisdictions with the lowest incidence rate were Dakota
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County Health Department (1.68), Douglas County Health Department and Southeast District
Health Department each with a rate of 2.54, and Sarpy/Cass Health Department (2.75).

Figure 5. WNV Cumulative Incidence Rate per 100,000 by Local Health Department
Jurisdiction, Nebraska, 2005-2021.
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WNF cumulative incidence rates per 100,000 population for each LHD jurisdiction can
be seen in Figure 6. The three LHD jurisdictions with the highest cumulative WNF incidence
rates were West Central District Health Department (15.07), Panhandle Public Health District
(11.71), and Loup Basin Public Health Department (11.52). The three LHD jurisdictions with the
lowest cumulative WNF incidence rates per 100,000 were Sarpy/Cass Health Department (1.28),
Dakota County Health Department (1.40), and Douglas County Health Department (1.43).
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Figure 6. WNF Cumulative Incidence Rate per 100,000 by Local Health Department
Jurisdiction, Nebraska, 2005-2021.

WNND cumulative incidence rates per 100,000 population for each LHD jurisdiction can
be seen in Figure 7. The three LHD jurisdictions with the highest cumulative WNND incidence
rates were Four Corners Health Department (3.73), West Central District Health Department
(3.13), and North Central District Health Department (2.66). The three LHD jurisdictions with
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the lowest cumulative WNF incidence rates per 100,000 were Dakota County Health Department
(0.28), South Heartland District Health Department (0.64), and Lincoln-Lancaster County Health
Department (1.05).

Figure 7. WNND Cumulative Incidence Rate per 100,000 by Local Health Department
Jurisdiction, Nebraska, 2005-2021.

23

Figure 8 depicts an epidemiological curve depicting both WNND and WNF case onset
dates based on the epidemiological calendar week. The graph illustrates that WNV disease onset
begins to steadily increase beginning in epidemiological week 21 (late May to early June) until it
peaks in week 36 (or early September). Case onset epidemiological weeks ranged from week 15
to week 52. WNND and WNF cases both follow a similar curve, peaking in week 36. WNND
does continue to have a large number of cases in weeks 37 and week 38 before tapering off.

Figure 8. Epidemiological Curve of Reported Human WNV Disease Onset Date, Nebraska,
2005-2021.
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Table 2 displays the univariate analysis on the predictor variables to determine if they
met a p-value cutoff of p<0.25 for entry into the multivariate logistic regression model. All
variable effects were found to be significant and were entered into the full model.

Table 2. Univariate Analysis for WNND development, Nebraska, 2005-2021.

Variables
Gender
Age Group
Rural Status
Ethnicity
Race

Crude P-Value
0.12
<0.0001
<0.0001
<0.0001
0.006

Table 3 displays the adjusted odds ratios, 95% confidence intervals, and p-values from
the logistic regression model for the development of WNND. During the stepwise selection
process, gender was not entered into the model due to the effect being non-significant (p>0.05).
The remaining predictors in the type 3 analysis of effects in this model were all significant.
There were several predictors that were significant including the 65+ age group, urban residence,
Hispanic ethnicity, and other race category. The estimated odds of developing WNND were 2.18
times greater for cases aged 65+ than the estimated odds of cases aged 45–64 (95% CI 1.55-3.06,
p <0.0001). For cases with an urban residence, odds of developing WNND were 2.18 times more
likely than the odds of cases with a rural residence (95% CI 1.64 – 2.89, p <0.0001). The
estimated odds of cases with Hispanic ethnicity were 2.35 times the odds of non-Hispanic cases
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(95% CI 1.00 – 5.52, p = 0.05). Finally, the estimated odds of cases with a race other than white
or black was 9.59 times the odds of white cases (95% CI 1.06—86.48, p = 0.04).

Table 3. Multivariate Analysis for WNND development, Nebraska, 2005-2021.

Variables
Age (year)
Ages 0-15
Ages 16-24
Ages 25-44
Ages 45-64
Ages 65+
Rural Status
Urban
Rural
Ethnicity
Hispanic or Latino
Non-Hispanic or Latino
Race
Black or African American
Other Race
White

Adjusted
Odds Ratio
Estimates

Adjusted 95%
Confidence
Interval

P-value

0.35
0.88
0.73
Reference
2.18

0.12 - 1.06
0.45 - 1.72
0.51 - 1.05
Reference
1.55 - 3.06

0.06
0.7
0.09
Reference
<0.0001

2.18
Reference

1.64 - 2.89
Reference

<0.0001
Reference

2.35
Reference

1.00 - 5.52
Reference

0.05
Reference

1.992
9.59
Reference

0.67 - 5.94
1.06 - 86.48
Reference

0.07
0.04
Reference
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Discussion
To my knowledge, this is the first report that summarizes the epidemiological
characteristics of WNV cases in Nebraska. Additionally, this report data spanned 17 years, which
incorporates some of the most recent data available and one of the longest time spans for
analysis.
The epidemiological curve revealed results consistent with previous research, with most
of the cases reporting illness onset between July – September [26]. Case counts varied widely
from year to year in Nebraska between 2005-2021, including three major outbreak years (2006,
2012, and 2018) during this time. These events happened in other states where WNV is endemic
as well; however, the etiology of outbreaks has yet to be determined.
Record low reported cases were seen as recently as 2020, which could possibly be
explained by the COVID-19 pandemic. While many people were reportedly spending more time
outdoors, thus increasing their potential exposure, healthcare utilization was also disrupted likely
leading to fewer WNF cases being reported. Overall, the average incidence for WNV disease
between 2005-2021 was 5.86 cases per 100,000 people. In comparison, research from the
Centers for Disease Control and Prevention (CDC) found that the United States average
incidence between 2009-2018, was 0.4 cases per 100,000 people [26]. North Dakota and South
Dakota also had significantly higher average incidence rates during that time (3.16 cases per
100,000 and 3.06 cases per 100,000, respectively) compared to Iowa, Kansas, and Missouri
(0.45, 0.51, and 0.22 cases per 100,000, respectively) [26]. Nebraska appears to have suitable
conditions for greater transmission compared to some neighboring states. Firstly, Nebraska sits
within a bird migration flyway and is a migration stopover site which increases the abundance of
available hosts for potential WNV transmission. Secondly, Nebraska has the most acres of
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irrigated land in the US, over 8.5 million acres, which creates a suitable breeding environment
for Culex tarsalis mosquitoes [30]. In comparison, Iowa, Kansas, and Missouri have significantly
fewer acres of irrigated land at 200,000 acres, 2.5 million acres, and 1.5 million acres,
respectively [30].
Additionally, differences in arboviral surveillance practices and funding makes it difficult
to assess differences in arboviral activity in the states that surround Nebraska. For example,
Kansas only recently (2017) expanded their mosquito surveillance from 1 county to 3 [31]. In
Iowa, according to a yearly report from 2013, mosquitos were trapped in 5 counties across the
state. Nebraska has 21 counties that trap mosquitos throughout the WNV season each year.
The annual incidence rates of both WNF and WNND in Nebraska overall appeared to
follow the expected trend of WNF having a higher incidence rate and to increase and decrease at
a similar rate. Most years, 2008-2017, this trend was observed. However, in 2005-2007, there
were notable difference in WNF incidence rates and WNND. There was a significant surge in
WNF annual incidence rate in 2006, with very little change or a decrease in the WNND
incidence rate. There were no WNND cases included in the analysis for 2006, which could be the
result of an outlier year in which no severe disease developed or the result of reporting bias
where appropriate testing was not done to trigger a case investigation. More recently, 2018-2021
has seen WNND annual incidence rate that is greater than the WNF incidence rate during this
time. This could be the result of fewer people seeking medical care for more mild symptoms,
especially in the COVID-19 pandemic years 2020 and 2021.
The incidence rates among the different LHD jurisdictions varied across the state. Central
and western Nebraska LHD jurisdictions (Panhandle Public Health District, Loup Basin Public
Health Department, and West Central District Health Department) had some of the highest
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cumulative WNV incidence rates between 2005-2021. The eastern half of Nebraska, specifically
the jurisdictions along the Missouri river, had some of the lowest cumulative incidence rates
which can, in some instances, be attributed to larger populations. The WNF and WNND
incidence maps also reflect that the western and central Nebraska LHD jurisdictions, which are
largely rural, have some of the higher incidence rates in the state. Agriculture and irrigation use
are likely contributors to the higher incidence rates in these areas of the state. Different mosquito
species also prefer different breeding environments as well. Specifically, Culex tarsalis, the
prominent vector for WNV in Nebraska, breeds primarily in irrigated agriculture areas [10].
Conversely, Culex pipiens, also capable of WNV transmission, favor urban areas and often breed
in standing water (i.e., bird baths, tire piles, etc.) [10].
Males made up a larger proportion of cases for both WNF and WNND cases (55% and
61%, respectively), which was consistent with other research [15, 17-19, 21-23]. Interestingly,
male sex was not found to be a significant predictor for developing WNND, which is in contrast
to other research [15,22-23]. It is unclear if mosquito exposure for males and females is different
in Nebraska compared to other states, suggesting that additional research is necessary. While a
large portion of the race and ethnicity data was unknown or unreported, of the data that was
collected, both WNF and WNND cases were predominantly non-Hispanic or Latino (36% and
49%, respectively) and white (43% and 63%, respectively). This can largely be explained by
Nebraska’s predominately non-Hispanic white population [27]. The 2021 Nebraska race and
ethnicity estimated that 77.4% of the population was non-Hispanic white, 12% were Hispanic or
Latino, and 5.3% were black [27]. Hispanic ethnicity and race other than white or black were
found to be significant predictors for developing WNND. While this might suggest there is a
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potential ethnic or racial disparity in WNND case development, more complete data collection
and additional research is needed to further support this finding.
Hospitalization, clinical symptoms, and deaths all represented expected findings with a
larger proportion of WNND cases being hospitalized (87%), accounting for all of the
neuroinvasive symptoms reported, and accounting for a majority of deaths (84%). Both WNF
and WNND cases had larger proportions of cases with rural residency (70% and 52%,
respectively). Urban residence was also found to be a predictor for the development of WNND,
which is interesting considering Nebraska’s large rural population [27].
There were several limitations in this study. One limitation of this study was that case
reporting in Nebraska is a passive surveillance system and reported cases are dependent on
health-care providers and laboratories. The result is a likely underestimation of true incidence,
specifically for WNF cases. Another limitation of the study was that case history is obtained by
LHD or in some instances NDHHS personnel. There are likely differences between jurisdictions
and completeness of the case history forms. Certain sections of the case report forms, such as
race and ethnicity as well as symptoms, lacked a significant amount of data. Additionally, no
underlying disease is obtained in the case history, which could also be used to better identify
predictors for the development of WNND.
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Conclusion
WNV has been in Nebraska for 20 years, and throughout that time the state consistently
reports some of the largest case counts in the country. Incidence rates for Nebraska are much
higher than national averages and several surrounding states. Given how quickly WNV spread
across the US, the devastation that was caused in both human and bird populations (specifically
Corvid birds), and the recurrent outbreaks throughout the US, the need for WNV surveillance,
prevention, and research continues to be necessary. This is certainly not without its challenges.
Nebraska has a relatively small population dispersed over a large geographic area, which makes
prevention efforts challenging [26]. In addition, vectors, hosts, environment, human behavior,
and climate change all make predicting future WNV disease and disease prevention difficult.
Continually monitoring and developing a better understanding of the geographic distribution of
cases at a county or LHD jurisdiction level helps provide the best opportunity to direct the
necessary resources for disease prevention and mosquito control.
This project helped identify LHD jurisdictions with high case counts, high incidence rates
relative to jurisdictions within the state, and reveal demographic information. More complete
data collection and collecting new information such as underlying health conditions would be
beneficial for future analysis.
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Application of Public Health Competencies
Foundational Competency: MPHF19 Communicate audience-appropriate public health
content, both in writing and through oral presentation. Competency MPHF19 was integrated
into this capstone project through the capstone presentation and the capstone paper. These items
provide public health content on WNV burden in Nebraska, and present epidemiological findings
that can be understood by all public health students, faculty, and staff.
Concentration Competency: EPIMPH3 Analyze datasets using computer software. This
competency was applied to this project in multiple ways. Firstly, the descriptive data analysis,
univariate and bivariate analysis was done utilizing SAS Studio 3.8 (Enterprise Edition)
software. Secondly, Microsoft Excel was utilized to display different information such as WNV
case totals by year, cumulative disease onset date by month, and annual incidence trends.

Concentration Competency: EPIMPH4 Utilize analytical approaches to describe,
summarize and interpret epidemiological data. Competency EPIMPH4 builds on the previous
competency EPIMPH3, in that the data being analyzed, summarized, and interpreted for a
capstone paper. The output from the analysis (i.e., graphs, tables, and maps) were used to help
illustrate and describe the WNV burden in Nebraska.
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Appendix A

LUKE MURPHY
16592 SW Sunshine Coast St | Tigard, OR 97224 | 402-659-5947 | lmurphy402@gmail.com

PROFESSIONAL EXPERIENCE
Clinical Study Coordinator
University of Nebraska Medical Center
09/2019 – Present
Omaha, NE
– Coordinate patient participation in clinical trials.
– Recruit and screen subjects; ensuring informed consent is obtained for assigned trials.
– Educate subjects regarding the study, schedule clinical visits and procedures under the direction of
the Principal Investigator.
– Coordinate the collection and testing of laboratory samples, including shipping to off-site
laboratories.
– Ensure compliance with protocol guidelines and requirements for regulatory agencies.
– Serve as liaison between internal departments and external entities for regulatory and protocol
compliance.
– Assist other researchers, nurses, CRAs and Lead Nurses involved in research trials.
– Collect, document, and organize study related information.
– Design and develop data collection tools, complete case report forms, and various forms to use for
screening, data collection, data entry, and data set management.
– Audit data and create reports.
Clinical Research Technician
University of Nebraska Medical Center
Omaha, NE
–
–
–

Process specimens collected for research according to the unique study protocol, and in compliance
with all requirements of the study sponsor.
Assist with specimen collection scheduling and ordering on an as-needed basis.
Laboratory management, including lab processing coverage and supply management.

Clinical Perfusionist
Essentia Health
Fargo, North Dakota
–
–

12/2018 – Present

08/2016 – 12/2018

Operation and management of the Heart-Lung Machine during cardiopulmonary bypass surgery.
Operation of mechanical support devices (ECMO, VAD).

SKILLS
Administrative
-

Clinical study management
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-

Project management
Laboratory management

Software
-

Microsoft Office
Electronic medical records systems (EPIC)
Statistical software (SAS)

Communication
-

Excellent verbal and written communication with physicians, staff, and patients

Problem-solving
-

Ability to identify and adapt to potential problems in a timely manner.

EDUCATION
University of Nebraska Medical Center
Master of Public Health
Omaha, NE
– Concentration: Epidemiology
– Expected graduation: December 2022
University of Nebraska Medical Center
Certificate in Public Health
Omaha, NE

2020-Present

2019-2020

University of Nebraska Medical Center
Master of Perfusion Science

2014 - 2016

Omaha, NE
–

Research Capstone Project:
o “The Effect of Transfusion of Hemoconcentrated Salvaged Blood Compared to Cell
Washed Salvaged Blood on the Thromboelastograph During Cardiopulmonary Bypass
Simulation.”

Rockhurst University
Bachelor of Science

2010 – 2014

Kansas City, MO
–
–

Major: Biology
Minor: Psychology
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